For decades, one of medicines most stubborn challenges hasnt been discovering new drugs, its making sure patients actually take them. Missed doses, delayed schedules, and incomplete treatments quietly undermine even the most advanced therapies, contributing to hundreds of thousands of preventable deaths and billions of dollars in healthcare costs every year.
A new scientific review highlights the rapid evolution of microneedle technology as a versatile and minimally invasive platform for delivering biomacromolecules—large therapeutic molecules used to treat major diseases, including cancer, cardiovascular conditions, metabolic disorders, infections, and autoimmune diseases.
To support the effective implementation of NUHM at the central level, the Consultant will provide technical, managerial, and analytical support and work closely with states and urban local bodies.
Master in Science / Public Health from a recognized University from a recognized institution OR Pharm.D (Doctor of Pharmacy) from a recognized institution Thorough knowledge of medical literature databases and statistical software is essential for the project work.
Expert-level capability in MS PowerPoint to create executive-level presentations for senior ministry officials. Strong verbal and written communication skills with an ability to synthesize complex data into concise reports.
M.Pharm Pharmaceutical Chemistry / MSc Chemistry. Candidate having Experience in organic synthesis, analytical instruments, and animal handling will be preferred.Development, Evaluation and Clinical Validation of Fluorescent Molecules to Target Alzheimer Disease.
Chittaranjan National Cancer Institute, CNCI is founded with the objective of serving as a premier Regional Cancer Centre, RCC for the Eastern Region of the Country. Pharm.D or M.Pharm Pharmacy Practice from an institution approved by the Pharmacy Council of India Fresher can apply
Zydus Lifesciences Limited has completed the acquisition of biologics manufacturing facilities from U.S.-based Agenus Inc., marking a major step in its global biologics and contract development and manufacturing (CDMO) strategy. Following regulatory clearances, including approval from the Committee on Foreign Investment in the United States (CFIUS), the acquired assets will operate under a newly formed U.S. subsidiary, Zylidac Bio LLC.
CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a premier multidisciplinary research institute of Council of Scientific and Industrial Research (CSIR), India with its major focus on exploiting the potential of medicinal and aromatic plants (MAPs) by cultivation, bioprospection, chemical characterization, extraction, and formulation of bioactive phytomolecules.
Candidates must have M.Sc. in Biochemistry, clinical Biochemistry, biotechnology/Life Sciences from a recognized university. Candidate must have submitted the PhD thesis. Institute for Stem Cell Science & Regenerative Medicine
Preference will be given to candidates who are Ready to relocate in Dewas and Ready to work in shifts. Good Communication Skills. Good Subject Knowledge
Sentynl Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZYCUBO® (copper histidinate) for the treatment of patients with Menkes disease, a rare, inherited disorder that affects copper absorption and distribution in the body.